Physician profile
Richard Covington
NPI 1073510053
$1,571.89
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,572.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $277.09 | 2019 | |
| Janssen Biotech, INC. | $203.22 | 2019 | |
| Astellas Pharma US INC | $162.12 | 2019 | |
| Lilly USA, LLC | $160.27 | 2019 | |
| Merck Sharp & Dohme LLC | $137.77 | 2019 | |
| Glaxosmithkline, LLC. | $126.44 | 2019 | |
| Janssen Pharmaceuticals, INC | $61.01 | 2019 | |
| Valeritas, INC. | $56.77 | 2019 | |
| Amarin Pharma, INC. | $39.47 | 2019 | |
| Ucb, INC. | $39.21 | 2019 | |
| Pacira Therapeutics, INC. | $37.76 | 2019 | |
| Shire North American Group INC | $35.49 | 2019 | |
| Antares Pharma, INC. | $27.61 | 2019 | |
| Allergan, INC. | $23.64 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.03 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $21.74 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $19.34 | 2019 | |
| Abbvie INC. | $16.02 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.36 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.91 | 2019 | |
| Corcept Therapeutics | $12.35 | 2019 | |
| Mannkind Corporation | $11.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Covington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.